State of the art for depression
This month’s Nature Neuroscience includes an interesting editorial on what might really be happening with monoamine-targeted antidepressenants (ie. like SSRIs). The article suggests that downstream effects might be the actual regulators of emotional mood; for example, serotonin is known to both increase neurotrophin production and induce neurogenesis.
Full article is here.